Prestige Estates Share Price In Focus; Launched prestige palm court in North Chennai

Prestige Palm Court an upcoming project in Madhavaram, North Chennai by Prestige Estates Projects. This project is being built on 7.98 acres along Grand Northern Trunk Road.
The project consists of five towers containing 910 apartments. The homes will be ranging from 1, 2 and 3 bedrooms each with saleable areas ranging of the abode available from 641 sq ft to 1,827 sq ft.
₹1,330 Crore Project
The saleable area of Prestige Palm Court is approximately 1.38 million sq ft.
The company has projected the Gross Development Value (GDV) of the project at ₹1,330 crore.
Also Check: Realty Stocks
910 Homes Across Five Towers
The project will consist of five G + 22 floors each comprising two numbers of Basement.
Available for buyers will be 1, 2 and 3-bedroom homes. The development is intended to provide luxury housing in the Madhavaram locality.
Part of Chennai Expansion
The debut is a shot in the arm of Prestige Group's residential business expansion programme in Chennai.
The firm intends to be launched three to four residential projects in the Chennai region in this financial year.
Read More: Fino Payments Bank Share Price in Focus; Receives RBI Approval to Extend Interim CEO Tenure!
Prestige Estates Share Price Performance
Prestige Estates share price closed at ₹1,588.00 per share on 27 August 2026, reflecting a decline of 2.16% from the previous trading session.
Conclusion
Prestige Estates projects for Prestige Palm Court located at Madhavaram with total 910 apartments, In 7.98 acres. The project has a saleable area of approximately 1.38 million sq ft and an estimated gross development value (GDV) of ₹1,330 crore. The launch is also in line with the company's aim of introducing more residential projects in Chennai this financial year.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Turn insights into action - Open Free Demat Account with Angel One and start investing instantly.
Published on: Aug 28, 2026, 5:46 PM IST

Team Angel One
- Aurobindo Pharma Share Price in Focus; USFDA Issues One Observation for Telangana Facility
- ACME Solar Share Price in Focus; Commissions 66.68 MW Solar and 300 MWh BESS Capacity in Rajasthan
- Apollo Micro Systems Share Price in Focus; Awarded Transfer of Technology for Semi Active Laser Homing System
- Bharat Forge Share Price in Focus; Partners with Pratt & Whitney Canada for DRDO’s HALE UAV Programme
- Infosys Share Price in Focus; Board to Consider September Quarter Results and Interim Dividend on October 23, 2026


